RDRobert Duncan

Robert Duncan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Robert Duncan has a total of 188 co-authors. Here are the top co-authors by number of shared publications:

  • Hira L. Nakhasi

    Division of Emerging and Transfusion Transmitted Diseases, OBRR, CBER, FDA, Silver Spring, Maryland

    19 shared publications
  • Poonam Salotra

    ICMR-National Institute of Pathology, Safdarjung Hospital Campus, New Delhi 110029, India

    14 shared publications
  • Angamuthu Selvapandiyan

    Infectious Diseases, Institute of Molecular Medicine , New Delhi 110020

    10 shared publications
  • Sreenivas Gannavaram

    Division of Emerging and Transfusion Transmitted Diseases, CBER, FDA, Silver Spring, MD, USA

    9 shared publications
  • Hira L. Nakhasi

    Division of Emerging and Transfusion Transmitted Diseases, CBER, FDA, Silver Spring, MD, USA

    8 shared publications
  • Carolyn Fisher

    Affiliation Division of Emerging and Transfusion-Transmitted Diseases, Office of Blood Research and Review, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, United States of America

    7 shared publications

Latest Publications

  • Open Access

    Tracking ebolavirus genomic drift with a resequencing microarray

    by Irina Tiper, Moussa Kourout, Bryan Lanning, Carolyn Fisher, Krishnamurthy Konduru, Anjan Purkayastha, Gerardo Kaplan, Robert Duncan

    Filoviruses are emerging pathogens that cause acute fever with high fatality rate and present a global public health threat. During the 2013–2016 Ebola virus outbreak, genome sequencing allowed the study of virus evolution, mutations affecting pathogenicity and infectivity, and tracing the viral spread. In 2018, early sequence identification of the Ebolavirus as EBOV in the Democratic Republic of the Congo supported the use of an Ebola virus vaccine. However, field-deployable sequencing methods are needed to enable a rapid public health response. Resequencing microarrays (RMA) are a targeted method to obtain genomic sequence on clinical specimens rapidly, and sensitively, overcoming the need for extensive bioinformatic analysis. This study presents the design and initial evaluation of an ebolavirus resequencing microarray (Ebolavirus-RMA) system for sequencing the major genomic regions of four Ebolaviruses that cause disease in humans. The design of the Ebolavirus-RMA system is described and evaluated by sequencing repository samples of three Ebolaviruses and two EBOV variants. The ability of the system to identify genetic drift in a replicating virus was achieved by sequencing the ebolavirus glycoprotein gene in a recombinant virus cultured under pressure from a neutralizing antibody. Comparison of the Ebolavirus-RMA results to the Genbank database sequence file with the accession number given for the source RNA and Ebolavirus-RMA results compared to Next Generation Sequence results of the same RNA samples showed up to 99% agreement.


  • The use of laser‐based diagnostics for the rapid identification of infectious agents in human blood

    by Rosalie A. Multari, David A. Cremers, Ann Nelson, Zohreh Karimi, Stephen Young, Carolyn Fisher, Robert Duncan

    Aims To investigate the use of a laser‐based method of detection as a potential diagnostic test for the rapid identification of infectious agents in human blood. Methods and Results In this study, the successful differentiation of blood spiked with viruses, bacteria, or protozoan parasites to clinically relevant levels is demonstrated using six blood types (O+, O‐, AB+, A+, A‐, B+) using blood from different individuals with blood samples prepared in two different laboratories. Experiments were performed using various compositions of filters, experimental set‐ups, and experimental parameters for spectral capture. Conclusions The potential for developing a laser‐based diagnostic instrument to detect the presence of parasites, bacteria and viruses in human blood capable of providing analysis results within minutes was demonstrated. Significance and Impact of the Study There is an ongoing need for clinical diagnostics to adapt to newly emerging agents and to screen simultaneously for multiple infectious agents. A laser‐based approach can achieve sensitive, multiplex detection with minimal sample preparation and provide rapid results (within minutes). These properties along with the flexibility to add new agent detection by simply adjusting the detection programming make it a promising tool for clinical diagnosis.


  • Advances in multiplex nucleic acid diagnostics for blood-borne pathogens: promises and pitfalls - an update

    by Robert Duncan, Elena Grigorenko, Carolyn Fisher, Donna Hockman, Bryan Lanning

    Introduction: Multiplex nucleic acid diagnostics for blood-borne pathogens have moved closer to clinical application in the two years since we first reviewed this topic. Areas covered: A new emphasis on detecting pathogens directly in a blood sample without culture, coupling PCR amplification to microfluidic devices and higher multiplexing in isothermal amplification are some of the advances. A wholly new approach of correlating host gene expression response with specific infectious agents opens another opportunity for multiplex detection. Established microarrays, which had been the highest multiplicity platform, are being displaced by Next Generation Sequencing (NGS) having potentially no limit to the number of pathogens that it can identify. Greater accessibility of sequencing devices, standardization of bioinformatic analysis pathways and increased acceptance from regulatory authorities are driving this technology. Expert commentary: The landscape of traditional diagnostics for detection of blood-borne pathogens has changed in the last 5 years. There is no doubt that NSG is recognized as a disruptive technology with a growing repertoire of tools, such as subtyping, resistome analysis, etc., available for clinical microbiology. Increasing acceptance indicates the dominating position of NGS as the future of multiplex molecular diagnostics for blood-borne pathogens.


  • Open Access

    Outcomes for Elderly Patients With Atypical Femoral Fractures Compared to Typical Femoral Fractures for Length of Stay, Discharge Destination, and 30-Day Mortality Rate

    by Dominic Davenport, James Duncan, Robert Duncan, Alastair Dick, Mohit Bansal, Max R. Edwards

    Despite increasing recognition of atypical femoral fractures (AFFs), there’s conflicting evidence about incidence, aetiology, and short-term outcomes of these injuries. This study reports the incidence of AFFs at our center and compares the early postoperative outcomes against typical femoral fractures (TFFs). A retrospective observational cohort study of patients presenting to our trauma unit between November 2015 and July 2016 was undertaken. Inclusion criteria required radiologically confirmed proximal femoral fracture, which was then categorized as AFF or TFF. Primary outcome measures included length of stay, discharge destination, and 30-day mortality. Two hundred thirty-nine patients presented to our trauma unit over 9 months with either a fractured neck of femur or proximal femoral fracture. A total of 122 were identified as pertrochanteric, subtrochanteric, or proximal femoral shaft fractures of which 25 (20.5%) displayed atypical radiographic features consistent with AFF. The 2 groups were similar for average age (TFF 85.3 years vs AFF 85.0 years), gender (19% vs 16% male gender), American Society of Anaesthesiology grade (3.0 vs 3.0), cognitive score (abbreviated mental test score = 7.03 vs 7.08), and preinjury place of residence (88.9% vs 92.0% lived in own home). Typical fractures were fixed with either dynamic hip screw or intramedullary nailing, all atypical fractures were fixed with intramedullary nailing. There was no statistical difference between the 2 groups for length of stay (12.8 days vs 14.3 days; P > .05), discharge to preinjury residence (45.1% vs 36%; P > .05), or 30-day mortality (8.1% vs 12%; P > .05). In our predominantly geriatric population atypical radiographic features were observed in around 10% of patients presenting with proximal femoral fractures or fractured neck of femur. Previous studies have reported poor outcomes for pain, mobility, and length of stay after AFF. However, we observed no difference in short-term outcome measures when compared to patients with typical proximal femoral fracture patterns at our trauma unit. With modern principles of trauma care outcomes achieved following AFFs may be equivalent to typical femoral fractures in the geriatric population.


  • Highly Multiplex Real-Time PCR–Based Screening for Blood-Borne Pathogens on an OpenArray Platform

    by Elena Grigorenko, Carolyn Fisher, Sunali Patel, Valerie Winkelman, Phillip Williamson, Caren Chancey, Germán Añez, Maria Rios, Victoria Majam, Sanjai Kumar, et al.


  • Comparison of multiplex PCR hybridization-based and singleplex real-time PCR-based assays for detection of low prevalence pathogens in spiked samples

    by Donna Hockman, Ming Dong, Hong Zheng, Sanjai Kumar, Matthew D. Huff, Elena Grigorenko, Maureen Beanan, Robert Duncan


  • Multiplex detection and identification of viral, bacterial, and protozoan pathogens in human blood and plasma using a high‐density resequencing pathogen microarray platform

    by Moussa Kourout, Carolyn Fisher, Anjan Purkayastha, Clark Tibbetts, Valerie Winkelman, Phillip Williamson, Hira L. Nakhasi, Robert Duncan

    BACKGROUND: The implementation of nucleic acid–based tests for blood donor screening has improved the safety of the blood supply; however, the increasing number of emerging pathogen tests is burdensome. Development of multiplex testing platforms that allow simultaneous screening for different pathogens is a potential solution.STUDY DESIGN AND METHODS: The TessArray resequencing microarray is a platform that allows multiplex detection and identification of 97 different blood‐borne pathogens in one single test. The objective was to evaluate the lowest concentration detected in blood or plasma, species discrimination, and applicability of the TessArray microarray platform for testing blood donors. Human blood or plasma spiked with selected pathogens (10,000, 1000, or 100 cells or copies/mL), including three viral, four bacterial, and four protozoan pathogens were each tested on this platform. The nucleic acids were extracted, amplified using multiplexed sets of pooled specific primers, fragmented, labeled, and hybridized to a microarray. Finally, the detected sequences were identified using an automated genomic database alignment algorithm.RESULTS: The performance of this platform demonstrated detection for spiked bacterial and protozoan pathogens of 100 cells/mL and viral pathogens as low as 100 copies/mL. Coded specimens, including spiked and negative controls, were identified correctly for blood specimens (31/32, 97%) and for plasma specimens (20/22, 91%) demonstrating the effectiveness of the platform.CONCLUSION: These results indicated that the TessArray microarray platform could be employed for multiplex detection and identification, with a high level of discriminatory power for numerous blood‐borne pathogen targets with potential for use in blood safety.


  • Open Access

    Standardized methods to generate mock (spiked) clinical specimens by spiking blood or plasma with cultured pathogens

    by M. Dong, C. Fisher, G. Añez, M. Rios, H.L. Nakhasi, J.P. Hobson, M. Beanan, D. Hockman, E. Grigorenko, R. Duncan

    Aims To demonstrate standardized methods for spiking pathogens into human matrices for evaluation and comparison among diagnostic platforms. Methods and Results This study presents detailed methods for spiking bacteria or protozoan parasites into whole blood and virus into plasma. Proper methods must start with a documented, reproducible pathogen source followed by steps that include standardized culture, preparation of cryopreserved aliquots, quantification of the aliquots by molecular methods, production of sufficient numbers of individual specimens and testing of the platform with multiple mock specimens. Results are presented following the described procedures that showed acceptable reproducibility comparing in‐house real‐time PCR assays to a commercially available multiplex molecular assay. Conclusions A step by step procedure has been described that can be followed by assay developers who are targeting low prevalence pathogens. Significance and Impact of the Study The development of diagnostic platforms for detection of low prevalence pathogens such as biothreat or emerging agents is challenged by the lack of clinical specimens for performance evaluation. This deficit can be overcome using mock clinical specimens made by spiking cultured pathogens into human matrices. To facilitate evaluation and comparison among platforms, standardized methods must be followed in the preparation and application of spiked specimens.


  • Advances in multiplex nucleic acid diagnostics for blood-borne pathogens: promises and pitfalls

    by Robert Duncan, Moussa Kourout, Elena Grigorenko, Carolyn Fisher, Ming Dong

    (2016). Advances in multiplex nucleic acid diagnostics for blood-borne pathogens: promises and pitfalls. Expert Review of Molecular Diagnostics: Vol. 16, No. 1, pp. 83-95.


  • Are Burn Patients Really at Risk for Thrombotic Events?

    by Shevonne S. Satahoo, Punam P. Parikh, Daniel Naranjo, James S. Davis, Robert C. Duncan, Louis R. Pizano, Nicholas Namias, Carl I. Schulman

    There continues to be debate about the routine use of deep vein thrombosis (DVT) prophylaxis in burn patients. The concern is that routine prophylaxi